Trials / Recruiting
RecruitingNCT03901235
MSC Intratissular Injection in Crohn Disease Patients
Treatment of Refractory Crohn's Disease Lesions by Local Injection of Mesenchymal Stem Cells
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- University of Liege · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective is to assess the efficacy of local injection of MSC on the healing of refractory intestinal and perianal lesions in crohn disease. The second co-primary endpoint is safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Mesenchymal Stromal Cells | Suspension of mesenchymal stromal cells for intratissular injection |
Timeline
- Start date
- 2018-01-15
- Primary completion
- 2025-12-31
- Completion
- 2026-12-31
- First posted
- 2019-04-03
- Last updated
- 2024-12-12
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03901235. Inclusion in this directory is not an endorsement.